Prescription costs increase for low-value treatments despite reduction in numbers

May 22, 2018, SAGE Publications

Despite a fall in prescription numbers for low-value treatments, the overall cost of prescribing these items in English primary care has risen, according to new research published by the Journal of the Royal Society of Medicine. NHS England has identified low-value treatments deemed to be ineffective, over-priced and of low clinical value, in order to increase value from the £17.4bn NHS medicines bill. The researchers found a strong association between practices with a higher proportion of patients over 65 and low-value prescribing. They also found prescribing behaviour clustered by Clinical Commissioning Group (CCG), the NHS bodies responsible for planning and commissioning health care services in their local area.

The researchers, from the Nuffield Department of Primary Care Health Sciences, University of Oxford, assessed the current use of low-priority treatments identified by NHS England, their change in use over time and the extent and reasons for variation in prescribing.

In addition to the national results presented in the paper, the researchers also shared all data on prescribing at all individual NHS practices. This is published through an interactive website, OpenPrescribing.net, which can be used by GPs, local commissioners, and even patients, to see where there are possible savings opportunities for individual prescribers.

Lead researcher Dr. Ben Goldacre said: "There were almost one million fewer for low-value items between July 2016 and June 2017, compared with the previous year. Despite the consistent downward trend in items, have risen, increasing by £4.5m when comparing 2016/17 with 2015/16.

The researchers found that while the cost per item has remained stable for most low-value treatments, for three items identified by NHS England, liothyronine (for hypothyroidism), trimipramine (an antidepressant) and co-proxamol (a painkiller), the cost has risen dramatically, by £73, £168 and £71 per prescription, respectively.

Dr. Goldacre said: "Co-proxamol, liothyronine and trimipramine illustrate a concerning phenomenon, where despite successful efforts to limit prescribing numbers, costs have risen sharply." Giving co-proxamol as an example Dr. Goldacre explained: "It's expensive because it was removed from the drug tariff, meaning that any prescriptions for it have to be sourced as a 'special' order. There is limited regulation of the cost of such special orders, making real world cost savings on such drugs difficult until there are a very small number of total prescriptions."

The researchers found that the strongest association with the level of prescribing cost at practice level was with the proportion of patients over 65, although they noted that this is perhaps not surprising given that older patients are generally more likely to receive prescriptions.

Commenting on the large degree in variation according to CCG, Dr. Goldacre said: "This is likely to be due to differences in policy between different CCGs and practices, rather than clinical need."

Explore further: Practices with poor prescribing performance more likely to prescribe homeopathy

More information: Trends and variation in prescribing of low-priority treatments identified by NHS England: a cross-sectional study and interactive data tool in English primary care, Journal of the Royal Society of Medicine (2018). journals.sagepub.com/doi/full/ … 177/0141076818769408

Related Stories

Practices with poor prescribing performance more likely to prescribe homeopathy

April 18, 2018
New research published today by the Journal of the Royal Society of Medicine finds that general practices in England with the worst prescribing quality scores are 2.1 times more likely to prescribe homeopathy than practices ...

Huge variation in prescribing practice for gluten-free foods in England

April 16, 2018
Prescribing practice for gluten free foods in England varies hugely, and doesn't seem to be driven by obvious medical factors, reveals research published in the online journal BMJ Open.

Surgeries employing GPs with additional training in complementary medicine appear less likely to pre

March 19, 2018
Use of complementary/alternative medicine may help reduce over prescribing of antibiotics

Effect of an opioid prescribing protocol on provider prescribing behavior

March 23, 2018
At the 47th Annual Meeting of the American Association for Dental Research (AADR), held in conjunction with the 42nd Annual Meeting of the Canadian Association for Dental Research (CADR), Chad Lowell Wagner, University of ...

Levels of inappropriate antibiotic prescribing in England estimated to be 20%

February 27, 2018
Research published by Public Health England (PHE) estimates that at least 20% of all antibiotic prescriptions written in primary care in England are inappropriate. This implies that antibiotic prescribing nationally should ...

Giving GPs feedback on their prescribing habits can reduce excessive use of antibiotics

February 19, 2016
Sending general practitioners (GPs) in England a letter giving feedback on their antibiotic prescribing habits could cut unnecessary prescriptions of antibiotics, according to the first nationwide randomised trial of its ...

Recommended for you

Discovery opens door for synthetic opioids with less addictive qualities

June 1, 2018
Making opioids from sugar instead of from field grown opium poppies has the potential to solve many of the problems associated with manufacturing strong pain killers.

US doctors prescribing fewer opioid painkillers: report

May 31, 2018
US doctors reduced the number of prescriptions for opioid painkillers last year, continuing a five-year trend, in an effort to reverse a deadly drug abuse epidemic, a report released Thursday said.

Researchers publish study on new therapy to treat opioid use disorder

May 22, 2018
Better delivery of medications to treat opioid use disorder (OUD) is key to addressing the opioid crisis and helping the 2.6 million Americans affected by the disease.

Could nonprofit drug companies cut sky-high prices?

May 17, 2018
(HealthDay)—Generic prescription drugs should be cheap, but prices for some have soared in the United States in recent years. Now a group of U.S. hospitals thinks it has a solution: a nonprofit drug maker.

Fewer antibiotics for kids, but more ADHD drugs

May 15, 2018
(HealthDay)—American kids are taking fewer prescription medications these days—but certain drugs are being prescribed more than ever, a new government study finds.

Opioid makers' perks to docs tied to more prescriptions

May 14, 2018
Doctors who accept perks from companies that make opioid painkillers are more likely to prescribe the drugs for their patients, new research suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.